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Objectives: An aberrant right hepatic artery (aRHA) is the most frequently encountered vascular
anomaly during pancreatoduodenectomy (PD). This study was performed to investigate the incidence of
aRHA in a large series of PDs and to explore its relationship with complications and survival.
Methods: In a consecutive series of 790 PDs, aRHA could be identified or ruled out in 758 patients by
reviewing operation reports. Patients with and without aRHA were compared. Main outcome measures
were complications and survival (only in patients with a malignancy).
Results: The aRHA group consisted of 143 patients (19%). Characteristics of patients in the aRHA and
normal RHA groups were comparable. There were no differences in surgical complications. The aRHA
was preserved without damage in 130 patients (91%). Two patients in whom the aRHA was either
sacrificed or damaged suffered complications (haemorrhage and intra-abdominal abscess in the right
upper quadrant) that may have been related. Longterm survival in patients with a malignancy and an
aRHA was not compromised.
Conclusions: An aRHA is frequently encountered during PD. Preservation is generally feasible without
compromising survival in patients with malignant tumours. Surgical morbidity is not higher in patients with
an aRHA. Preservation is technically possible in most patients and does not negatively impact on
outcomes.
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Introduction
Pancreatoduodenectomy (PD) represents the only chance for cure
in patients with a pancreatic or periampullary tumour and is
therefore the procedure of choice.1 It is a complex surgical proce-
dure that is associated with high morbidity rates of up to 50%.
Some of the most feared postoperative complications are anasto-
motic leakage at the site of pancreaticojejunostomy or hepaticoje-
junostomy, and post-pancreatectomy haemorrhage.2–6
Morbidity after PD may be even higher in the presence of
aberrant hepatic arterial supply, which is reported to occur in up
to 49% of patients.7–9 Anatomic variations in the hepatic arterial
supply increase the risk of complications through several mecha-
nisms. There is a higher risk of intraoperative vascular injury,
especially when aberrant arteries are encountered unexpectedly or
are not recognized promptly.10 Damage or ligation of an aberrant
artery may induce bile duct or liver ischaemia, which can lead to
breakdown of the bilioenteric anastomosis and liver dysfunction
or abscesses.11 Excessive manipulation while trying to preserve an
aberrant artery may result in damage to the vessel’s adventitia and
thus make it more prone to the formation of pseudoaneurysms,
especially in the presence of pancreaticojejunostomy
leakage.12 This implies a higher risk for life-threatening bleeding
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complications. Attempts to preserve aberrant vessels may also
hinder radical oncological resections.
Normal hepatic arterial supply involves a common hepatic
artery (CHA) arising from the coeliac trunk (Fig. 1). The section of
artery subsequent to the branching off of the gastroduodenal and
right gastric arteries is referred to as the proper hepatic artery; this
bifurcates into the right and left hepatic arteries (RHA and LHA).
The two most widely accepted classifications of hepatic arterial
variations are those by Michels, based on 200 autopsies, and Hiatt,
based on 1000 angiographic analyses (Table 1).7,9 In both series,
the most common reported vascular anomaly is an aberrant RHA
(aRHA) (Fig. 2). Michels makes a distinction between a replaced
and accessory aRHA. A replaced RHA (rRHA) arising from the
superior mesenteric artery (SMA) is classified as Michels type III.
It may course posterior to the pancreas, as well as within the
pancreatic parenchyma or along the ventral side of the pancreas.
Reported incidences vary from 8% to 14%.8,9,13,14 An accessory
RHA (accRHA) follows the same course as a rRHA, in addition to
a normal RHA. It is classified as Michels type VI and is reported to
occur in up to 7% of patients.8,9 In the Hiatt classification, both
rRHA and accRHA are classified as type III and reported inci-
dences vary from 7% to 21%.7,15–17
An aRHA represents the vascular anomaly encountered most
frequently during PD and, because of its course, is the hepatic
arterial anomaly that is most susceptible to intraoperative damage
and tumour involvement.14
Therefore, the aim of the present study was to investigate the
incidence of aRHA in a large cohort of patients undergoing PD
and to explore its relationships with the occurrence of complica-
tions and with longterm survival in patients with a malignancy.
Materials and methods
Patients and study outline
In a consecutive series of 790 PDs performed from 1992 to 2009,
clinicopathological data, perioperative outcomes and longterm
follow-up were prospectively recorded. Patients with an aRHA
were identified by reviewing operation reports. In cases of doubt,
preoperative computed tomography scans were reviewed to deter-
mine aberrant or normal RHA anatomy. The present study
involved a retrospective analysis of anonymized data, for which
Dutch ethical review board regulations do not require informed
consent.
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Figure 1 Normal hepatic arterial anatomy. RH, right hepatic artery;
MH, middle hepatic artery; LH, left hepatic artery. (Source: Blumgart
et al.25)
Table 1 Overview of the Michels and Hiatt classifications of hepatic
artery types
Description Michels
type
Hiatt
type
Normal anatomy I I
Replaced LHA from LGA II II
Replaced RHA from SMA III III
Replaced RHA + LHA IV IV
Accessory LHA V II
Accessory RHA VI III
Accessory RHA + LHA VII IV
Replaced RHA + accLHA or
replaced LHA + accRHA
VIII IV
CHA from SMA IX V
CHA from LGA X –
CHA from aorta – VI
LHA, left hepatic artery; LGA, left gastric artery; RHA, right hepatic artery;
SMA, superior mesenteric artery; acc, accessory; CHA, common hepatic
artery
Figure 2 Computed tomography scan showing a replaced right
hepatic artery (white arrow) arising from the superior mesenteric
artery
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It was possible to reliably identify or rule out an aRHA in 758
patients. According to these findings, patients were divided into
aberrant (n = 143, 19%) and normal (n = 615, 81%) RHA groups.
Outcome measures
For each study group, the following surgical complications were
analysed: delayed gastric emptying; pancreaticojejunostomy
leakage and post-pancreatectomy haemorrhage (each according
to its consensus definition by the International Study Group of
Pancreatic Surgery, grades B or C); hepaticojejunostomy leakage;
primary intra-abdominal abscess; wound infection, and other sur-
gical complications.18–20 Other short-term outcome measures were
re-laparotomy, hospital mortality and length of hospital stay. In
patients undergoing surgery for a malignancy, survival time was
an additional outcome measure.
Surgical procedure
The standard surgical procedure was a pylorus-preserving PD. A
classic Whipple procedure was reserved for patients with tumour
ingrowth in the pylorus or duodenum. The standard procedure
has been described earlier.21 In short, after resectability had been
assessed and an extensive Kocher manoeuvre to evaluate local
tumour ingrowth in the vena cava, aorta or SMA had been carried
out, the hepatoduodenal ligament was explored. This is the sur-
gical step during which an aRHA was usually encountered. Upon
discovery, the aRHA was generally followed caudally in the direc-
tion of its origin. However, it was not always followed to its origin
if there was clearly no tumour involvement of the aRHA.
In cases of limited tumour ingrowth in the portal or superior
mesenteric vein, a segmental or wedge resection was carried out.22
Reconstruction was performed by retrocolic hepaticojejunostomy
and pancreaticojejunostomy and retrocolic or antecolic duode-
nojejunostomy, without Roux-en-Y reconstruction. One silicone
drain was left in the foramen of Winslow near the hepaticojejun-
ostomy and pancreaticojejunostomy.21 A feeding jejunostomy
procedure was standard until 2000, since when it has been per-
formed only for indications of severe weight loss or malnutri-
tion.23 Octreotide was routinely administered subcutaneously
until 2002, since when it has been administered only in cases of
soft pancreas or non-dilated pancreatic duct.
Statistical analysis
Depending on the data distribution, results are reported as mean
 standard deviation (SD) or median with interquartile range
(IQR). Independent samples t-test (for normally distributed data)
and Mann–Whitney U-test (for abnormally distributed data) were
used to compare continuous variables between the study groups.
The chi-squared test was used for categorical data. Kaplan–Meier
estimates of survival were obtained in patients undergoing
surgery for a malignancy. Overall survival was compared
between the normal and aberrant RHA groups, using log-rank test
statistics.
P-values of <0.05 were considered statistically significant. All
analyses were performed in spssVersion 16.0 (SPSS, Inc., Chicago,
IL, USA).
Results
Patient and operation characteristics
Characteristics of patients in the aberrant and normal RHA
groups are summarized in Table 2. There were no significant dif-
ferences in terms of age, sex, American Society of Anesthesiolo-
gists class or co-morbidity. The pathological entity for which PD
was performed did not differ between the two groups (Table 3). In
both groups, 83% of patients were operated for a malignant
lesion.
Operation variables did not differ between the two groups
(Table 4). In eight patients (6%) with aRHA, the aberrant vessel
was willingly sacrificed, for oncological (n = 6) or technical (n = 2)
reasons. In one of these patients, reconstruction was considered,
but was not performed after intraoperative Doppler ultrasonog-
raphy showed normal antegrade arterial liver perfusion. In five
patients (3%) the aberrant vessel was accidentally damaged (n = 2)
Table 2 Characteristics of patients with and without aberrant right hepatic artery
Patient characteristic Aberrant RHA (n = 143) Normal RHA (n = 615) P-value
Mean age (SD), years 60.7 (11.4) 62.3 (11.0) 0.14
Males, n (%) 79 (55) 344 (56) 0.88
ASA classification, n (%)
I 35 (25) 126 (21) 0.30
II 87 (61) 372 (61)
III/IV 20 (14) 116 (19)
Co-morbidity, n (%)
Cardiac 25 (18) 133 (22) 0.26
Pulmonary 11 (8) 78 (13) 0.09
Diabetes mellitus 18 (13) 95 (16) 0.38
Hypertension 28 (20) 129 (21) 0.70
RHA, right hepatic artery; SD, standard deviation; ASA, American Society of Anesthesiologists
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or ligated (n = 3). This occurred mainly during bile duct dissec-
tion. The two damaged aRHAs were repaired by primary closure
with prolene 6–0. Of the three accidentally ligated aRHAs, one was
reconstructed by end-to-end anastomosis.
Right hepatic arterial variations
Table 5 provides an overview of the RHA variations encountered
in the aRHA group. The most common variations were rRHA and
accRHA (Hiatt type III). In 45 of 127 (35%) patients with a Hiatt
type III aRHA, whether the RHA was replaced or accessory could
not be distinguished with certainty.
Nine patients (1%) had both aRHA and aLHA (Hiatt type IV).
Seven patients (1%) had a replaced CHA arising from the SMA
(Hiatt type V). These were grouped in the aRHA group for the
purpose of this analysis.
Short-term outcomes
There was no difference in overall surgical morbidity and no
difference in rates of any of the surgical complications between
the two groups (Table 6). Incidences of complications that might
be related to the presence of an aRHA, such as haemorrhage,
hepaticojejunostomy leakage or intra-abdominal abscess, were
comparable in both groups. Hospital mortality, re-laparotomy
rate and length of hospital stay did not differ between the aberrant
and normal RHA groups.
In the 13 patients in whom the aRHA was either willingly
sacrificed or accidentally damaged or ligated, two complications
Table 5 Right hepatic arterial variations observed in 758
pancreatoduodenectomies
Variation n (%)
Aberrant RHA 127 (17)
Replaced RHA 60 (8)
Accessory RHA 22 (3)
Replaced OR accessory RHA 45 (6)
Aberrant RHA and LHA 9 (1)
Replaced RHA and LHA 4 (1)
Accessory RHA and LHA 4 (1)
Replaced OR accessory RHA and LHA 1 (0)
Aberrant CHA 7 (1)
Replaced CHA 7 (1)
Total 143 (19)
RHA, right hepatic artery; LHA, left hepatic artery; CHA, common hepatic
artery
Table 3 Underlying disease in patients with and without aberrant right hepatic artery undergoing pancreatoduodenectomy
Aberrant RHA (n = 143) Normal RHA (n = 615) P-value
Malignant disease, n (%) 119 (83) 508 (83) 0.86
Pathological entity, n (%)
Pancreatic adenocarcinoma 55 (39) 216 (35) 0.38
Ampullary adenocarcinoma 33 (23) 144 (23)
Distal common bile duct adenocarcinoma 22 (15) 76 (12)
Duodenal carcinoma 0 (0) 17 (3)
Other (pre)malignant disease 14 (10) 66 (11)
Chronic pancreatitis 13 (9) 55 (9)
Other benign disease 6 (4) 41 (7)
RHA, right hepatic artery
Table 4 Surgical variables in patients with and without aberrant right hepatic artery
Aberrant RHA (n = 143) Normal RHA (n = 615) P-value
Operation
Pylorus preserved, n (%) 128 (90) 535 (87) 0.41
Mean duration of operation (SD), min 299 (91) 300 (86) 0.96
Median estimated blood loss (IQR), mla 1100 (963) 1050 (1200) 0.88
Aberrant right hepatic artery handling
Preserved, n (%) 130 (91) –
Sacrificed, n (%) 8 (6) –
Accidentally damaged or ligated, n (%) 5 (3) –
aCalculated in 99 patients with aberrant RHA and 398 patients with normal RHA
RHA, right hepatic artery; SD, standard deviation; IQR, interquartile range
164 HPB
HPB 2011, 13, 161–167 © 2011 International Hepato-Pancreato-Biliary Association
that may be related occurred: one patient suffered a delayed
massive haemorrhage, and the other was readmitted with a large
intra-abdominal abscess in the right upper quadrant after making
an initially good recovery (Table 7). However, there were no dif-
ferences between the aRHA and normal RHA groups in terms of
surgical complications, hospital mortality, re-laparotomy rate or
length of hospital stay.
Longterm survival
Figure 3 shows the Kaplan–Meier survival curves of patients with
malignancy, with and without aRHA. Median survival times did
not differ significantly between the groups and were 25.7 months
in the aRHA group and 29.4 months in the normal RHA group
(log-rank test, P = 0.67). If only patients with pancreatic cancer
were taken into account, median survival times in the aRHA (n =
55) and normal RHA (n = 215) groups were also similar, at 17.9
months in the aRHA group and 19.1 months in the normal RHA
group (log-rank test, P = 0.92).
Discussion
Anatomic variations in the hepatic arterial supply are a common
phenomenon. The vascular anomaly encountered most frequently
during PD is the aRHA. Preservation of an aRHA during PD may
lead to compromised cancer resections, whereas damage or liga-
tion may lead to bleeding complications and liver or bile duct
ischaemia and subsequent breakdown of the bilioenteric
anastomosis.
In the present study, 18% of patients had an aRHA; an addi-
tional 1% had a replaced CHA arising from the SMA. The pres-
ence of an aRHA did not lead to more complications and did not
influence longterm survival in patients with a malignancy.
The incidence of aRHA in the current series (17% incidence of
Hiatt type III variations [either rRHA or accRHA]) accords well
with rates reported in previous publications.7,15,17,24 The operation
reports did not always distinguish between replaced and accessory
anomalies (i.e. Michels type III or VI). However, in the 82 patients
Table 6 Short-term outcomes after pancreatoduodenectomy in patients with and without aberrant right hepatic artery
Aberrant RHA (n = 143) Normal RHA (n = 615) P-value
Surgical complications, n (%) 80 (56) 303 (49) 0.15
Pancreaticojejunostomy leakagea 18 (13) 87 (14) 0.63
Delayed gastric emptyinga 48 (34) 193 (31) 0.61
Post-pancreatectomy haemorrhagea 11 (8) 44 (7) 0.82
Hepaticojejunostomy leakage 2 (1) 21 (3) 0.21
Primary intra-abdominal abscess 7 (5) 25 (4) 0.66
Wound infection 16 (11) 55 (9) 0.41
Other 18 (13) 70 (12) 0.71
Re-laparotomy, n (%) 10 (7) 68 (11) 0.15
Hospital mortality, n (%) 2 (1) 13 (2) 0.58
Median hospital stay (IQR), days 15 (11) 14 (11) 0.94
aInternational Study Group of Pancreatic Surgery definition, grade B or C
RHA, right hepatic artery; IQR, interquartile range
Table 7 Short-term outcomes after pancreatoduodenectomy in patients with ligated or damaged aberrant vs. normal right hepatic artery
Ligated or damaged
aberrant RHA (n = 13)
Normal RHA (n = 615) P-value
Surgical complications, n (%) 7 (54) 303 (49) 0.74
Pancreaticojejunostomy leakage 3 (23) 87 (14) 0.36
Delayed gastric emptying 4 (31) 193 (31) 0.96
Post-pancreatectomy haemorrhage 1 (8) 44 (7) 0.94
Hepaticojejunostomy leakage 0 (0) 21 (3) 0.50
Primary intra-abdominal abscess 1 (8) 25 (4) 0.52
Wound infection 1 (8) 55 (9) 0.87
Other 1 (8) 70 (12) 0.67
Re-laparotomy, n (%) 3 (23) 68 (11) 0.18
Hospital mortality, n (%) 1 (8) 13 (2) 0.18
Median hospital stay (IQR), days 12 (14) 14 (11) 0.68
RHA, right hepatic artery; IQR, interquartile range
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whose surgical reports clearly stated whether the aberrant vessel
represented a replaced or accessory RHA, the majority (n = 60,
73%) were replaced, as might be expected according to previously
published incidences of Michels type III and VI variations.8,9,13
Nine patients (1%) showed Hiatt type IV variations (aRHA and
aLHA). In four of these, both aberrant vessels were replaced. This
is, to our knowledge, the first surgical study on hepatic arterial
variations to describe this variant.12 Seven patients (1%) had a
replaced CHA arising from the SMA (Hiatt type V). This inci-
dence is somewhat lower than those reported in previous
series.8,9,24
In the vast majority of patients with aRHA, the aberrant vessel
could be preserved. In eight patients it was willingly sacrificed,
mainly for oncological reasons. Five aRHAs were accidentally
damaged (n = 2) or ligated (n = 3), two of which were not recon-
structed. Thus, the number of patients in whom the aRHA was
permanently lost totalled 10 (7%). Lee et al. described a series of
103 PDs in which 15 aRHAs were encountered and all were pre-
served.14 Jah et al. found 28 aRHAs in 135 PDs; three of these were
divided and one of the three was anastomosed to the gastroduode-
nal artery stump, leading to two permanently lost aRHAs (7%).15
Turrini et al. reported a series in which two of 47 aRHAs needed
reconstruction and one was ligated.17
Morbidity in the aRHA group did not differ from that in the
normal RHA group, which is similar to findings in the smaller
series by Lee et al.,14 Jah et al.15 and Turrini et al.17 Even in the
current series of more than 750 PDs, which included a large aRHA
group of 143 patients, no differences were found in rates of sur-
gical complications, not even for those complications that might
be expected to occur more frequently in patients with an aRHA,
such as hepaticojejunostomy leakage, bleeding complications and
intra-abdominal abscess.
Morbidity in the subgroup of patients in whom aRHAs were
sacrificed, accidentally damaged or ligated was comparable with
that in the non-aRHA group. The numbers in this subgroup were
probably too small to detect possible differences in morbidity,
although complications that may be related did occur in two
patients in whom the aRHA was sacrificed.
Longterm survival was not compromised in patients operated
for a malignancy. These results confirm the findings of Lee et al.,14
Jah et al.15 and Turrini et al.17 and show that preservation of aRHA
is feasible in the vast majority of patients and does not decrease
overall longterm survival in patients with a malignancy.
A limitation of the current study is its retrospective identifi-
cation of aRHA, which may have led to an underestimation of
the incidence of aRHA. It was not possible to distinguish between
replaced and accessory variants in a substantial number of
reports; this distinction would have been possible if the aRHA
had been recorded prospectively. However, a comparison
between the incidence of aRHA in the current study and those in
the current literature does not suggest an underestimation; we
believe an aRHA is such an important intraoperative finding that
surgeons will always mention it in their reports. Another limita-
tion of the retrospective collection of aRHA data is that preop-
erative knowledge of the presence of the aRHA could not be
analysed. In the local multidisciplinary hepatopancreatobiliary
meeting, aRHAs are usually identified and discussed during the
review of preoperative imaging, but the finding is not routinely
mentioned in radiologists’ imaging reports, a fact also noted by
Turrini et al.17
In conclusion, the current study describes the incidence and
consequences of aRHA in the largest surgical series to be used for
this purpose to date. It is the first surgical report to describe
patients with both rRHA and rLHA. It shows that aRHA is a
common phenomenon and that preservation of the aRHA is gen-
erally feasible and does not compromise longterm survival in
patients with a malignancy. Sacrifice or accidental damage or liga-
tion of aRHAs may raise the risk for complications such as liver
dysfunction or hepaticojejunostomy leakage, however, the
number of patients in this subgroup in this series was too small to
detect eventual differences. It is our belief that an aRHA can nearly
always be preserved, without negatively impacting surgical out-
comes and longterm survival in patients with a malignancy. Given
the high incidence of aRHA, it is suggested that radiologists
should include hepatic arterial anatomy in their standard preop-
erative imaging reports.
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